IMPAACT 2047; Phase II, Randomized Study of the Pharmacokinetics, Safety and Tolerability of High Dose Rifapentine given with Moxifloxacin for Tuberculosis during Pregnancy. Radiant-Moms Plus: Rifapentine in High Doses in Pregnancy with TB Grant uri icon

Overview

date/time interval

  • January 1, 2025 - November 30, 2025

sponsor award ID

  • 5 UM1 AI068632-19

Affiliation